Implantable cardiac defibrillators (ICD) are effective in reducing mortality in patient populations at risk for sudden cardiac death, but transvenous ICDs are associated with complications such as infections, pneumothorax, venous thrombosis, lead dislodgement, lead malfunction, and haemopericardium. In this Review, Lewis and Gold describe a novel design of entirely subcutaneous ICDs that avoid some of the complications of transvenous systems, and explore the advantages and disadvantages of both ICD systems.
- Geoffrey F. Lewis
- Michael R. Gold